The focus on how BMI should be used may have overshadowed an equally, if not more important, matter proposed in a new report.

A major new study has revealed a long list of benefits and some little-known risks of Ozempic and other GLP-1 medications.

Just as quickly, investors are losing their appetite for the trade. After a disappointing trial of a new Novo Nordisk drug ...

Overweight scores continue from 25-30. And over 30 is obese. Quetelet merely used this early calculation as a descriptor. He did not make any medical proclamations. The Quetelet Index became ...

The diabetes startup is prescribing GLP-1 drugs for weight loss to help employers manage costs. Its CEO says it's nearing ...

A report from The Lancet Diabetes & Endocrinology Commission has proposed new criteria for defining and diagnosing obesity, ...

If you’ve been diagnosed with major depressive disorder, seasonal affective depression or any other type of depression, your ...

The discussion shed light on the complex relationships people have with food and the urgent need for robust action to address ...

Donald Trump is a huge fan - but a raft of studies suggest we may not completely escape the negative effects of fizzy drinks ...

However, Pfizer's revenue guidance for 2025 doesn't look particularly exciting. The company expects its top line to come in ...

The reason is unclear but experts say those with the condition often engage in unhealthy habits and struggle to access health care.

Experts said "unhealthy habits" and "risk taking behaviour" could be a partial cause, with more supported needed for those ...